Namenda Xr Oral Capsule, Extended Release 14Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Namenda XR: Oral capsule, extended release (14mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_18479.JPG
Namenda XR 14mg ER Capsule
Allergan USA, Inc.
Pill Identification: FLI 14 mg 

What is this Medicine?

MEMANTINE (MEM an teen) is used to treat dementia caused by Alzheimer's disease.

CVS Pharmacy Patient Statistics for Namenda XR: Oral capsule, extended release(14mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Namenda XR 14mg Extended-Release Capsule

NDC: 004563414
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Alzheimer's Disease

Sometimes used for but not FDA approved for the following conditions:
Nystagmus

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Namenda XR 14mg Extended-Release Capsule
Drug Image file DrugItem_18479.JPG
Allergan USA, Inc.
Pill Identification: FLI 14 mg 
Shape: capsule
Color: green,yellow

Reported Side Effects for Namenda XR 14mg Extended-Release Capsule

Low Blood Pressure Incidence:
2.0%*
Severity: MODERATE
Onset: RAPID
Tired Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Uncontrolled Urination Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Stomach Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
2.0-3.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Hallucinations Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Weight Gain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
3.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Flu Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
4.0%*
Severity: MODERATE
Onset: EARLY
Cough Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
5.0-7.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
6.0%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
6.0-8.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Second Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Third Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Namenda XR

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.